These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 25089614

  • 1. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK, Melinder A.
    Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
    [Abstract] [Full Text] [Related]

  • 2. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN, Bos AF.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2873-4. PubMed ID: 18257430
    [Abstract] [Full Text] [Related]

  • 3. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.
    Arch Gen Psychiatry; 2012 Jul 29; 69(7):706-14. PubMed ID: 22393202
    [Abstract] [Full Text] [Related]

  • 4. Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.
    Hermansen TK, Røysamb E, Augusti EM, Melinder A.
    Psychopharmacology (Berl); 2016 Apr 29; 233(8):1523-35. PubMed ID: 26924747
    [Abstract] [Full Text] [Related]

  • 5. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD, Åkerud H, Sundström Poromaa I.
    Eur J Pharmacol; 2015 Apr 15; 753():257-62. PubMed ID: 25094036
    [Abstract] [Full Text] [Related]

  • 6. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.
    Psychopharmacology (Berl); 2011 Sep 15; 217(2):211-9. PubMed ID: 21499702
    [Abstract] [Full Text] [Related]

  • 7. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 8. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence.
    Oberlander TF, Gingrich JA, Ansorge MS.
    Clin Pharmacol Ther; 2009 Dec 29; 86(6):672-7. PubMed ID: 19890255
    [Abstract] [Full Text] [Related]

  • 9. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V, Ververs TF, Visser GH, Gazzolo D.
    Curr Med Chem; 2012 Dec 29; 19(27):4554-61. PubMed ID: 22876893
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun 29; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 11. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL, Brain UM, Underhill CM, Hammond GL, Oberlander TF.
    Psychoneuroendocrinology; 2012 Jul 29; 37(7):1019-28. PubMed ID: 22177580
    [Abstract] [Full Text] [Related]

  • 12. [Selective serotonin reuptake inhibitors and pregnancy].
    Hassanzadeh T, Pedersen LH, Videbech P.
    Ugeskr Laeger; 2014 Feb 03; 176(3):236-9. PubMed ID: 24629751
    [Abstract] [Full Text] [Related]

  • 13. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov 03; 97(6):F472-6. PubMed ID: 23080479
    [Abstract] [Full Text] [Related]

  • 14. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
    Koc D, Tiemeier H, Stricker BH, Muetzel RL, Hillegers M, El Marroun H.
    JAMA Psychiatry; 2023 Dec 01; 80(12):1208-1217. PubMed ID: 37647036
    [Abstract] [Full Text] [Related]

  • 15. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE, Gilbert AL, Sørensen TI, Olsen J, Sørensen HT, Pedersen LH, Morrison JL.
    Ann Epidemiol; 2013 Nov 01; 23(11):681-7. PubMed ID: 24113367
    [Abstract] [Full Text] [Related]

  • 16. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.
    JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine during pregnancy: impact on fetal development.
    Morrison JL, Riggs KW, Rurak DW.
    Reprod Fertil Dev; 2005 Nov 01; 17(6):641-50. PubMed ID: 16263070
    [Abstract] [Full Text] [Related]

  • 18. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N, Williams LJ, Muller AM, Abdi H, Virji-Babul N, Bjornson BH, Brain U, Werker JF, Grunau RE, Miller SP, Oberlander TF.
    Depress Anxiety; 2019 Aug 01; 36(8):753-765. PubMed ID: 31066992
    [Abstract] [Full Text] [Related]

  • 19. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C, Cha J, Hong S, Bastidas V, Weissman M, Fifer WP, Myers M, Talati A, Bansal R, Peterson BS, Monk C, Gingrich JA, Posner J.
    JAMA Pediatr; 2018 Jun 01; 172(6):525-533. PubMed ID: 29630692
    [Abstract] [Full Text] [Related]

  • 20. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 01; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.